Christopher L. Tucker
Thanks, Bryan. Everyone can follow along on the chart presentation. We will start on Page 3, which shows the financial highlights for the quarter. Before jumping into the numbers, I do want to point out that we are looking at everything on a continuing operations basis. Now that VACCO has been sold, it has been classified as a discontinued operation in our financial statements, so the commentary will exclude any P&L impacts for discontinued operations. Now turning to the numbers. You can see that, by all measures, ESCO delivered a great quarter. Orders showed a significant increase in the quarter. We will go through segment details coming up, but a big driver of the reported increase relates to the acquired backlog at Maritime. Excluding that, we still had good orders performance with a 1.3 book-to-bill ratio. We ended Q3 with backlog of nearly $1.2 billion, a new record for ESCO. Sales performance was also strong with growth in the quarter of nearly 27% on a reported basis and 11% on an organic basis, which excludes the impact of the Maritime acquisition. Adjusted EBIT margins increased from 19.3% last year to 21.1% in this year's third quarter. Lastly, adjusted earnings per share increased by 25% to $1.60 per share. I would also point out on the bottom right of the chart that we did have a sizable amount of add-backs for adjusted earnings. This was driven by the Maritime acquisition, where we had significant costs related to closing of the deal as well as inventory step-up charges, stamp duties in the U.K. and an increase in acquisition-related amortization. Next, we will go through the segment highlights, starting with Aerospace & Defense. Orders increased significantly, but you can see that $364 million of this related to the backlog acquired at Maritime. Beyond that, Maritime delivered another $50 million of orders in the 2 months they were owned by ESCO. On an organic basis, orders were also quite strong with Globe receiving large Virginia and Columbia Class orders. Backlog for A&D finished at $832 million. From a sales perspective, growth was up 56% on a reported basis and 14% organically. You can see the Maritime impact was significant, but the core business also performed very well. This translated nicely to margins, which increased over 500 basis points with positive contributions from across this set of businesses. The margin increase was due to favorable impacts from price, mix and leverage on the growth. Moving on to Chart 5, we have the Utility Solutions Group. Orders momentum remained healthy with growth of 5.5% in the quarter. This was driven by Doble, where orders increased nearly 7%, while NRG orders in the quarter were flat. On the sales side, growth was a bit more muted with only 2% growth. This lower growth was also driven by Doble, where timing of shipments resulted in lower revenue growth in the third quarter. We see this as a temporary issue and expect to return to higher growth in the fourth quarter. As you can see on the chart, backlogs are healthy and have increased nearly 15% compared to prior year-end. On the margin story -- on the margin front, the story is similar to sales with the margin drop in the quarter driven by Doble. On a year-to-date basis, the Utility Solutions Group has delivered adjusted EBIT margins that are 130 basis points ahead of last year's first 9 months. So while we have seen some weakness from NRG in the year, the Doble performance has been strong, and we feel good about the full year outlook there. Next, we will cover Test, where the team delivered another strong quarter, starting with orders where we did see a decline of nearly 6% in the quarter. We had some tough comparisons to last year but honestly feel good about where the business is trending. Year-to-date orders are up over 30%, and you can see that backlogs are up nearly 24% compared to year-end. So the momentum here has been strong during 2025. Sales were very good with a 20.7% increase, which drove adjusted EBIT to increase by 15.4%. Margins here were down slightly as we've experienced unfavorable mix and some tariff impacts. Year-to-date margins are up 140 basis points. So 2025 has been a positive step for this business after a couple of tough years in '23 and '24. Moving to Chart #7, we have year-to-date P&L highlights. As you can see, the results have been terrific through the first 9 months of 2025. Bryan mentioned all the portfolio work earlier, which is very important. This chart shows that the core company has continued to deliver, and we are now starting to see the impacts of the Maritime deal come through. Orders have been great. If you take out the Maritime backlog impact, we have growth of 17%. The sales story is also quite positive with A&D up 12% organically and nearly 28% when Maritime is added in. Test sales are up 15%, while the US growth -- USG growth is a bit more modest at 4% due to weakness for NRG so far this year. Earnings are up double digits with adjusted EBIT margins increasing by 200 basis points and all 3 segments posting nice margin improvement over the first 3 quarters of the year. Finally, adjusted earnings per share is up over 24%. So by any measure, the company has performed very well year-to-date in 2025. Next is Chart 8, where we have cash flow highlights. The first 9 months of fiscal 2025 delivered strong operating cash flow results as working capital performance has been favorable compared to the first 9 months of 2024. This is true for continuing operations, and it should be noted that the cash flow for discontinued operations was also quite strong through the first 9 months of fiscal 2025. Capital spending is up for the first 9 months due to various programs in the A&D and utility businesses. Our strong cash generation and the delay in getting the Maritime deal closed means that our leverage position is in good shape as of June 30 at 1.74x. With the VACCO divestiture getting finalized in July, we expect to have the balance sheet in great shape as we close out the year. Last, we will discuss updated guidance for the year, which is covered on Chart 9 and 10. Chart 9 is the words that go with Chart 10, so I'll just talk to Slide 10 here. Fundamentally, the guide represents another increase for us. You will remember that last quarter, we still had VACCO in the guidance, and we had included estimates for Maritime as well. Now we need to remove VACCO as that deal has now closed. That reduces sales projections by approximately $125 million and adjusted EPS comes down by approximately $0.50. For the continuing operations, we are increasing the guide for the year. On the sales side, we are coming up by $20 million at both the low end and the high end of the range. For adjusted earnings per share, we are tightening the range with only 1 quarter to go. So the bottom of the range is coming up by $0.40 and the high end is coming up by $0.25. This adjusted EPS range represents 21% to 24% growth compared to prior year. The additional sales is delivering nicely to the bottom line, and while we are seeing some tariff impact in the numbers, it is at the low end of our ranges that have been guided previously. So obviously, it is shaping up to be another record year at ESCO, and we are excited to share this updated outlook with you today. That concludes the financial portion of the call, and now I'll turn it back over to Bryan.